These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 32990414

  • 1. Inhibition of microglial receptor-interacting protein kinase 1 ameliorates neuroinflammation following cerebral ischaemic stroke.
    Jiao Y, Wang J, Zhang H, Cao Y, Qu Y, Huang S, Kong X, Song C, Li J, Li Q, Ma H, Lu X, Wang L.
    J Cell Mol Med; 2020 Nov; 24(21):12585-12598. PubMed ID: 32990414
    [Abstract] [Full Text] [Related]

  • 2. STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke.
    Li W, Shen N, Kong L, Huang H, Wang X, Zhang Y, Wang G, Xu P, Hu W.
    Stroke Vasc Neurol; 2024 Apr 30; 9(2):153-164. PubMed ID: 37402504
    [Abstract] [Full Text] [Related]

  • 3. Modulation of NLRP3 inflammasome-related-inflammation via RIPK1/RIPK3-DRP1 or HIF-1α signaling by phenothiazine in hypothermic and normothermic neuroprotection after acute ischemic stroke.
    Jiang Q, Ding Y, Li F, Fayyaz AI, Duan H, Geng X.
    Redox Biol; 2024 Jul 30; 73():103169. PubMed ID: 38692093
    [Abstract] [Full Text] [Related]

  • 4. JLX001 ameliorates cerebral ischemia injury by modulating microglial polarization and compromising NLRP3 inflammasome activation via the NF-κB signaling pathway.
    Bian HJ, Xu SY, Li HQ, Jia JQ, Ye L, Shu S, Xia SN, Gu Y, Zhu X, Xu Y, Cao X.
    Int Immunopharmacol; 2021 Dec 30; 101(Pt A):108325. PubMed ID: 34740080
    [Abstract] [Full Text] [Related]

  • 5. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling.
    Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y, Dong Y, Zhao T, Chen H.
    Int Immunopharmacol; 2016 Nov 30; 40():492-500. PubMed ID: 27769021
    [Abstract] [Full Text] [Related]

  • 6. Kv1.3 channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia.
    Ma DC, Zhang NN, Zhang YN, Chen HS.
    Exp Neurol; 2020 Oct 30; 332():113399. PubMed ID: 32652099
    [Abstract] [Full Text] [Related]

  • 7. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition.
    Zhu H, Jian Z, Zhong Y, Ye Y, Zhang Y, Hu X, Pu B, Gu L, Xiong X.
    Front Immunol; 2021 Oct 30; 12():714943. PubMed ID: 34367186
    [Abstract] [Full Text] [Related]

  • 8. Ginsenoside Rg1 ameliorates cerebral ischemia-reperfusion injury by regulating Pink1/ Parkin-mediated mitochondrial autophagy and inhibiting microglia NLRP3 activation.
    Sui C, Liu Y, Jiang J, Tang J, Yu L, Lv G.
    Brain Res Bull; 2024 Oct 01; 216():111043. PubMed ID: 39134096
    [Abstract] [Full Text] [Related]

  • 9. MitoQ attenuates brain damage by polarizing microglia towards the M2 phenotype through inhibition of the NLRP3 inflammasome after ICH.
    Chen W, Guo C, Huang S, Jia Z, Wang J, Zhong J, Ge H, Yuan J, Chen T, Liu X, Hu R, Yin Y, Feng H.
    Pharmacol Res; 2020 Nov 01; 161():105122. PubMed ID: 32791262
    [Abstract] [Full Text] [Related]

  • 10. Recombinant osteopontin provides protection for cerebral infarction by inhibiting the NLRP3 inflammasome in microglia.
    Zhang X, Shu Q, Liu Z, Gao C, Wang Z, Xing Z, Song J.
    Brain Res; 2021 Jan 15; 1751():147170. PubMed ID: 33157099
    [Abstract] [Full Text] [Related]

  • 11. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling.
    Zhao J, Piao X, Wu Y, Liang S, Han F, Liang Q, Shao S, Zhao D.
    Biomed Pharmacother; 2020 Jul 15; 127():110151. PubMed ID: 32559840
    [Abstract] [Full Text] [Related]

  • 12. Hirudin alleviates acute ischemic stroke by inhibiting NLRP3 inflammasome-mediated neuroinflammation: In vivo and in vitro approaches.
    Li WQ, Qin ZS, Chen S, Cheng D, Yang SC, Choi YMM, Chu B, Zhou WH, Zhang ZJ.
    Int Immunopharmacol; 2022 Sep 15; 110():108967. PubMed ID: 35724604
    [Abstract] [Full Text] [Related]

  • 13. Vagus nerve stimulation as a promising neuroprotection for ischemic stroke via α7nAchR-dependent inactivation of microglial NLRP3 inflammasome.
    Xia XM, Duan Y, Wang YP, Han RX, Dong YF, Jiang SY, Zheng Y, Qiao C, Cao L, Lu X, Lu M.
    Acta Pharmacol Sin; 2024 Jul 15; 45(7):1349-1365. PubMed ID: 38504011
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury.
    Gong Z, Pan J, Shen Q, Li M, Peng Y.
    J Neuroinflammation; 2018 Aug 28; 15(1):242. PubMed ID: 30153825
    [Abstract] [Full Text] [Related]

  • 15. Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation.
    Zhang Y, Li M, Li X, Zhang H, Wang L, Wu X, Zhang H, Luo Y.
    Cell Death Dis; 2020 Jul 23; 11(7):565. PubMed ID: 32703968
    [Abstract] [Full Text] [Related]

  • 16. NLRP3 inflammasome inhibitor ameliorates ischemic stroke by reprogramming the phenotype of microglia/macrophage in a murine model of distal middle cerebral artery occlusion.
    Jia H, Qi X, Fu L, Wu H, Shang J, Qu M, Yang C, Wang J.
    Neuropathology; 2022 Jun 23; 42(3):181-189. PubMed ID: 35434787
    [Abstract] [Full Text] [Related]

  • 17. Geniposide inhibits NLRP3 inflammasome activation via autophagy in BV-2 microglial cells exposed to oxygen-glucose deprivation/reoxygenation.
    Fu C, Zhang X, Lu Y, Wang F, Xu Z, Liu S, Zheng H, Liu X.
    Int Immunopharmacol; 2020 Jul 23; 84():106547. PubMed ID: 32361652
    [Abstract] [Full Text] [Related]

  • 18. RNA binding protein RPS3 mediates microglial polarization by activating NLRP3 inflammasome via SIRT1 in ischemic stroke.
    Zhou D, Chen L, Wang Y, Gan L, Yuan M, Zhang L, Chen F.
    J Stroke Cerebrovasc Dis; 2023 Jun 23; 32(6):107132. PubMed ID: 37087770
    [Abstract] [Full Text] [Related]

  • 19. Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures.
    Ślusarczyk J, Trojan E, Głombik K, Piotrowska A, Budziszewska B, Kubera M, Popiołek-Barczyk K, Lasoń W, Mika J, Basta-Kaim A.
    Int J Mol Sci; 2018 Jul 05; 19(7):. PubMed ID: 29976873
    [Abstract] [Full Text] [Related]

  • 20. PHLDA1 Blockade Alleviates Cerebral Ischemia/Reperfusion Injury by Affecting Microglial M1/M2 Polarization and NLRP3 Inflammasome Activation.
    Zhao H, Liu Y, Chen N, Yu H, Liu S, Qian M, Zhang Z.
    Neuroscience; 2022 Apr 01; 487():66-77. PubMed ID: 35093445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.